A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
Clinical trial NCT01416259 · COMPLETED
Trial details
- NCT number
- NCT01416259
- Sponsor
- Heron Therapeutics
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.